[Today's focus]

SMIC (00981.HK)'s third-quarter profit attributable to owners of $0.149 billion decreased 9.6% month-on-month

SMIC (00981.HK) announced that sales revenue for the third quarter of 2024 was USD 2171.2 million, the second quarter of 2024 was USD 1901.3 million, and the third quarter of 2023 was USD 1620.6 million. Gross profit for the third quarter of 2024 was $444.2 million, the second quarter of 2024 was $265.1 million, and the third quarter of 2023 was $321.6 million.

The gross margin for the third quarter of 2024 was 20.5%, the second quarter of 2024 was 13.9%, and the third quarter of 2023 was 19.8%. Profit attributable to company owners in the third quarter of 2024 was 0.149 billion US dollars, a decrease of 9.6% month-on-month and an increase of 58.3% year-on-year.

Guidelines for the fourth quarter of 2024: Quarterly revenue remained flat to 2% month-on-month; gross margin ranged from 18% to 20%.

[Important matters]

Zhongji Longevity Science (00767.HK) establishes a joint venture to be mainly engaged in providing longevity health services in China

[Financial results]

Huahong Semiconductor (01347.HK): Net profit of $44.8 million in the third quarter increased 222.6% year over year

Minghui International (03828.HK): Revenue of HK$1.687 billion increased 14.0% year-on-year in the first three quarters

Darewell Group (00341.HK) Profit Alert: Profit attributable to shareholders is expected to fall by no more than 30% in the medium term

Huaxin Real Estate Finance (00252.HK) Profit Warning: Expected medium-term loss of not more than HK$35 million

[Operational data]

Guangzhou Automobile Group (02238.HK) saw 17.23% year-on-year sales of 185,785 vehicles in October

[Pharmaceutical Innovation]

Le Meridien Vaccine (06660.HK): Iterative process for clinical registration of the high-cost human diploid rabies vaccine

Goli Pharmaceutical-B (01672.HK): A phase I clinical study of ASC47, the first of its kind to treat obesity for weight loss without muscle loss, achieved positive results in a phase I study conducted in Australia

Forsen Pharmaceutical (01652.HK): Piracetam injection marketing license application accepted

[Acquisition and sale]

Acer Capital (02288.HK) is negotiating with a third party on the sale of certain units and parking spaces in the Acer Capital Tower to resume trading on November 8

Baidley Holdings (06909.HK) successfully won a public bid to acquire a debt from Mengshang Bank

[Equity Incentives]

HSBC Holdings (00005.HK) grants 1.114 million reward shares

[Repurchase Cancellation]

HSBC Holdings (00005.HK) spent HK$0.342 billion to buy back 4.754 million shares on November 6

Alibaba-SW (09988.HK) spent 19.955 million dollars to buy back 1.654 million shares on November 6

Standard Chartered Group (02888.HK) spent £14.0213 million to buy back 1.4838 million shares on November 6

AIA (01299.HK) spent HK$61.83 million to buy back 1 million shares on November 7

COSCO Marine Holdings (01919.HK) spent HK$36.025 million to repurchase 2.9765 million shares on November 7

Prudential (02378.HK) spent £6.6677 million to buy back 1 million shares on November 6

Yum China (09987.HK) spent 2.4 million dollars to buy back 0.049 million shares on November 6

China Petroleum & Chemical Co., Ltd. (00386.HK) spent HK$13.31 million to buy back 3.05 million shares on November 7

Swire Group A (00019.HK) spent HK$12.43 million to buy back 0.1865 million shares on November 7

Pot Circle (02517.HK) spent HK$9.93 million to buy back 4.8 million shares on November 7

Baihong Industrial (02299.HK) cancelled 1.31 million shares and repurchased shares on November 7

China Automobile (00026.HK) cancelled 0.058 million shares and repurchased shares on November 7